Ultra-Fast Intraoperative IDH-Mutation Analysis Enables Rapid Stratification and Therapy Planning in Diffuse Gliomas
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26199639 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Theo F J Kraus und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pathology, University Hospital Salzburg, Paracelsus Medical University, Müllner Hauptstraße 48, A-5020 Salzburg, Austria. Hauptthemen laut MEDLINE: Isocitrate Dehydrogenase, Glioma, Brain Neoplasms, Mutation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Diffuse gliomas are the most common primary brain tumors in adults in the Western world. According to the 2021 World Health Organization (WHO) classification of central nervous system (CNS) tumors, the assessment of isocitrate dehydrogenase (IDH1/2)-mutation status is essential for accurate patient stratification. In this study, we performed a comprehensive evaluation of IDH-mutation status in the intraoperative setting using the Idylla platform. The reference cohort comprised 30 formalin-fixed paraffin-embedded (FFPE) tissue samples with known IDH status, while the exploration cohort included 35 intraoperative snap-frozen and native-tissue specimens. The results were compared with those of a standard next-generation sequencing (NGS) analysis. Our findings demonstrate that the Idylla IDH-mutation assay provides 100% concordance compared with NGS analysis for both FFPE and intraoperative tissue samples. The Idylla system delivers results within approximately 90 min, significantly outperforming NGS, which requires between 7 and 27 days. This rapid turnaround facilitates timely interdisciplinary case discussions and enables timely therapy planning, within the framework of neuro-oncological molecular tumor boards. The ultra-fast intraoperative IDH-mutation analysis using the Idylla platform, in combination with intraoperative histopathological assessment, enables rapid patient stratification and treatment planning in diffuse gliomas.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Pathology, University Hospital Salzburg, Paracelsus Medical University, Müllner Hauptstraße 48, A-5020 Salzburg, Austria.
- Department of Neurosurgery, University Hospital Salzburg, Paracelsus Medical University, Ignaz-Harrer-Straße 79, A-5020 Salzburg, Austria.
ORCID-Profile: Theo F J Kraus, Karl Sotlar
Zitieren
APA
Kraus, T. F. J., Alinger-Scharinger, B., Langwieder, C. K., Mol, A., Aleksic, T., van Merkestijn, B., Schlicker, H. U., Spendel, M., Pöppe, J., Schwartz, C., Griessenauer, C. J., & Sotlar, K. (2025). Ultra-Fast Intraoperative IDH-Mutation Analysis Enables Rapid Stratification and Therapy Planning in Diffuse Gliomas. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26199639
Vancouver
Kraus TFJ, Alinger-Scharinger B, Langwieder CK, Mol A, Aleksic T, van Merkestijn B, et al. Ultra-Fast Intraoperative IDH-Mutation Analysis Enables Rapid Stratification and Therapy Planning in Diffuse Gliomas. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26199639
BibTeX
@article{Kraus2025,
author = {Kraus, Theo F J and Alinger-Scharinger, Beate and Langwieder, Celina K and Mol, Anna and Aleksic, Tereza and van Merkestijn, Brain and Schlicker, Hans U and Spendel, Mathias and Pöppe, Johannes and Schwartz, Christoph and Griessenauer, Christoph J and Sotlar, Karl},
title = {Ultra-Fast Intraoperative IDH-Mutation Analysis Enables Rapid Stratification and Therapy Planning in Diffuse Gliomas},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26199639}
}
EUVIMED